Across TCGA pan-cancer cohorts, P2RX6P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated P2RX6P data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher P2RX6P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated P2RX6P expression acts as an unfavorable survival marker, although some lineages such as ACC and ESCA show a favorable association.
BRCA, ACC, and LUAD are the cancer types where P2RX6P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.